Samsung Epis Holdings Earns 'AA' Rating in Global ESG Assessment
Awarded Leader Rating in MSCI-Led ESG Assessment
Samsung Epis Holdings announced on May 14 that it has received an 'AA' rating, classifying it as a leader group in the ESG (Environmental, Social, and Governance) evaluation by Morgan Stanley Capital International (MSCI), a global investment information provider.
Exterior view of Samsung Bioepis building in Yeonsu-gu, Incheon. Samsung Bioepis
View original imageSamsung Epis Holdings, participating in a global ESG evaluation for the first time since its spin-off and listing in November last year, achieved a high rating from the world-renowned agency MSCI based on its various disclosed management achievements and ESG activities of its subsidiary, Samsung Bioepis.
MSCI is a New York-based company that provides global stock indices and authoritative investment information. Since 1999, it has evaluated the ESG management performance of listed companies worldwide and assigns ratings in seven levels, from AAA to CCC.
Among the three main evaluation criteria (Environment, Social, Governance), Samsung Epis Holdings received particularly high marks for its talent management and product safety and quality management in the Social category.
Kim Kyung-Ah, CEO of Samsung Epis Holdings, stated, "Achieving a leader rating in our first global ESG evaluation is not the result of short-term efforts, but rather the outcome of systematically preparing for ESG management as a core value since our establishment. We will continue to strengthen our ESG-based sustainable management system alongside patient-centered biopharmaceutical development."
Hot Picks Today
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- [Breaking] Samsung Electronics Management: "Tentative Agreement Will Be a Starting Point for a Cooperative Labor-Management Culture"
- "Was It You Again?" Elementary Student Involved in Last Week's Vehicle Theft Drives Off Himself This Time
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Meanwhile, since officially launching as a bio investment holding company in November last year, Samsung Epis Holdings has been pursuing a variety of new bio businesses, including biopharmaceuticals, new drug development, and technology platforms. In February, the company was also included as a component in the MSCI Korea Index, a key reference indicator for global investors in Korean companies, following MSCI’s regular review.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.